Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM® Across Rich, Medium, and Sparse Sampling Data-Reference-Cited by-同舟云学术

Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM® Across Rich, Medium, and Sparse Sampling Data

Published:2018-05-21 Issue:6 Volume:43 Page:729-736
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Sukarnjanaset Waroonrat,Wattanavijitkul Thitima^ORCID,Jarurattanasirikul Sutep

Funder

Chulalongkorn University graduate school thesis grant

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/article/10.1007/s13318-018-0484-8/fulltext.html

Reference13 articles.

1. Bauer RJ, Guzy S, Ng C. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples. AAPS J. 2007;9(1):E60–83.

2. Wang Y. Derivation of various NONMEM estimation methods. J Pharmacokinet Pharmacodyn. 2007;34(5):575–93.

3. Bauer RJ. Introduction to NONMEM 7 and higher. In: Bauer RJ, editor. NONMEM users guide: Introduction to NONMEM 742. Gaithersburg, MD: ICON Plc; 2018. p. 35.

4. Gibiansky L, Gibiansky E, Bauer R. Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model. J Pharmacokinet Pharmacodyn. 2012;39(1):17–35.

5. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via Em algorithm. J R Stat Soc B Methodol. 1977;39(1):1–38.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of stochastic simulation-estimation approach to the optimization of Pharmacokinetic studies design in the context of paediatric extrapolation: A step toward better decision making for drug sponsors and regulators;2024-05-08

2. Artificial Intelligence and Machine Learning in Pharmacokinetics and Pharmacodynamic Studies;Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications;2024

3. Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study;Pharmaceutics;2023-09-21

4. Population Pharmacokinetics and Pharmacodynamics of Vancomycin in Pediatric Patients With Various Degrees of Renal Function;The Journal of Pediatric Pharmacology and Therapeutics;2022-05-01

5. Population pharmacokinetic analysis of dexmedetomidine in children using real‐world data from electronic health records and remnant specimens;British Journal of Clinical Pharmacology;2022-01-28